Tamoxifen versus high-dose oral medroxyprogesterone acetate as initial endocrine therapy for patients with metastatic breast cancer: a Piedmont Oncology Association study. [electronic resource]
Producer: 19940825Description: 1630-8 p. digitalISSN:- 0732-183X
- Administration, Oral
- Adult
- Aged
- Aged, 80 and over
- Bone Neoplasms -- drug therapy
- Breast Neoplasms -- drug therapy
- Drug Administration Schedule
- Female
- Humans
- Liver Neoplasms -- drug therapy
- Medroxyprogesterone Acetate -- administration & dosage
- Middle Aged
- Prospective Studies
- Regression Analysis
- Soft Tissue Neoplasms -- drug therapy
- Survival Analysis
- Tamoxifen -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.